Lamotrigine Eg (Lamotrigine)

Lamotrigine works by blocking voltage‑gated sodium channels on neurons, which stabilizes neuronal membranes and reduces the release of excitatory neurotransmitters such as glutamate. This mechanism diminishes neuronal hyperexcitability, thereby controlling seizures and contributing to mood stabilization in bipolar disorder.

The dosage of Lamotrigine Eg is individualized and determined by the prescribing clinician. Factors such as the specific indication, patient age, weight, renal and hepatic function, and concomitant medications influence the appropriate dose and titration schedule.

The safety of lamotrigine during pregnancy and lactation is not fully established. It should only be used if the potential benefits justify the potential risks to the fetus or infant. Healthcare providers will assess each case and discuss possible alternatives or monitoring strategies.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamotrigine offers a broad spectrum of seizure control with a relatively favorable side‑effect profile compared with some older antiepileptics. Unlike enzyme‑inducing agents, it has fewer drug‑interaction concerns, but clinicians must still monitor for interactions with valproic acid, carbamazepine and hormonal contraceptives.

Lamotrigine Eg should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, heat and direct sunlight to maintain its stability and potency throughout its shelf life.

Lamotrigine Eg is taken orally, usually as a tablet, with or without food as directed by the prescriber. The tablet should be swallowed whole with water and not crushed or chewed unless specifically advised.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias, hepatic failure, and the emergence of suicidal thoughts or behaviors. Patients should seek immediate medical attention if they notice rash, fever, jaundice, or mood changes.

Lamotrigine Eg is contraindicated in individuals with a known hypersensitivity to lamotrigine or any of its excipients. Patients with a history of severe skin reactions to antiepileptic drugs should avoid it, and it should be used with caution in those with significant hepatic or renal impairment.